1-7 of 7
Keywords: Angiotensin-converting enzyme inhibitors
Close
Sort by
Journal Articles
Subject Area:
Nephrology
Nephron Clinical Practice (2011) 118 (4): c407–c419.
Published Online: 07 March 2011
... decades, more especially the widespread use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs). We note that many of the published large renin-angiotensin-aldosterone system (RAAS) blockade randomized controlled trials, upon which current evidence-based practice...
Journal Articles
Subject Area:
Nephrology
Nephron Clinical Practice (2010) 118 (1): c43–c48.
Published Online: 11 November 2010
... hypertension. Recent efforts have focused on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ACEIs/ARBs) in addition to enzyme replacement therapy (ERT) for treatment of Fabry nephropathy. The proven beneficial effects of ACEI/ARBs for more common forms of proteinuric...
Journal Articles
Subject Area:
Nephrology
Nephron Clinical Practice (2009) 113 (2): c63–c70.
Published Online: 14 July 2009
...Macaulay A. Onuigbo Despite reported renoprotection with angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs), and notwithstanding their increased use, we continue to experience an epidemic of acute renal failure (ARF)/chronic kidney disease/end-stage renal disease...
Journal Articles
Subject Area:
Nephrology
Nephron Clinical Practice (2009) 112 (4): c242–c247.
Published Online: 16 June 2009
...Anna Masajtis-Zagajewska; Michał Nowicki Background/Aims: Angiotensin II promotes sodium retention and influences the central regulation of fluid intake. Clinical studies on the effect of an angiotensin-converting enzyme inhibitor (ACEI) on xerostomia and thirst in chronic hemodialysis (HD...
Journal Articles
Subject Area:
Nephrology
Nephron Clinical Practice (2007) 105 (2): c77–c83.
Published Online: 01 December 2006
...Constança S. Cruz; Luzia S. Cruz; Giulliana R. Silva; Carlos A. Marcílio de Souza Background/Aims: Recent studies have shown high rates of morbimortality associated with hyperkalemia in congestive heart failure (CHF) patients treated with angiotensin-converting enzyme inhibitors (ACEI) plus...
Journal Articles
Journal Articles
Subject Area:
Nephrology
Nephron Clinical Practice (2005) 101 (3): c139–c149.
Published Online: 06 July 2005
...Mark S. MacGregor; Christopher J. Deighan; R.Stuart C. Rodger; J.Michael Boulton-Jones Background: Treatment of hypertension slows the progression of non-diabetic nephropathies, but the optimal regimen is unknown. Angiotensin-converting enzyme inhibitors are more effective than β-blockers...